Industry News
Imcyse Completes Enrollment in First-in-Human Phase 1b Study in Type 1 Diabetes
Excellent safety profile reported so far, results expected summer 2019
News & Articles
25
Selected Filters:
Industry News
Imcyse's Phase 1b Clinical Trial in Type 1 Diabetes Begins Patient Enrolment Across Four European Countries
A specific immunotherapy that could be used to stop the destruction of pancreatic cells in early stage diabetes